# Invasive Disease Caused by Group A Streptococcus (GAS) (DICAR)

> **NCT03507101** · — · UNKNOWN · sponsor: **Tampere University Hospital** · enrollment: 45 (actual)

## Conditions studied

- Invasive Group A Beta-Haemolytic Streptococcal Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03507101
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2024-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507101, "Invasive Disease Caused by Group A Streptococcus (GAS) (DICAR)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03507101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*